Anti-ZSWIM1 monoclonal antibody

Pre-made anti-ZSWIM1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ZSWIM1/ZSWIM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2851-Ab-1/ GM-Tg-hg-IP2851-Ab-2Anti-Human ZSWIM1 monoclonal antibodyHuman
GM-Tg-rg-IP2851-Ab-1/ GM-Tg-rg-IP2851-Ab-2Anti-Rat ZSWIM1 monoclonal antibodyRat
GM-Tg-mg-IP2851-Ab-1/ GM-Tg-mg-IP2851-Ab-2Anti-Mouse ZSWIM1 monoclonal antibodyMouse
GM-Tg-cynog-IP2851-Ab-1/ GM-Tg-cynog-IP2851-Ab-2Anti-Cynomolgus/ Rhesus macaque ZSWIM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2851-Ab-1/ GM-Tg-felg-IP2851-Ab-2Anti-Feline ZSWIM1 monoclonal antibodyFeline
GM-Tg-cang-IP2851-Ab-1/ GM-Tg-cang-IP2851-Ab-2Anti-Canine ZSWIM1 monoclonal antibodyCanine
GM-Tg-bovg-IP2851-Ab-1/ GM-Tg-bovg-IP2851-Ab-2Anti-Bovine ZSWIM1 monoclonal antibodyBovine
GM-Tg-equg-IP2851-Ab-1/ GM-Tg-equg-IP2851-Ab-2Anti-Equine ZSWIM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2851-Ab-1/ GM-Tg-hg-IP2851-Ab-2; GM-Tg-rg-IP2851-Ab-1/ GM-Tg-rg-IP2851-Ab-2;
GM-Tg-mg-IP2851-Ab-1/ GM-Tg-mg-IP2851-Ab-2; GM-Tg-cynog-IP2851-Ab-1/ GM-Tg-cynog-IP2851-Ab-2;
GM-Tg-felg-IP2851-Ab-1/ GM-Tg-felg-IP2851-Ab-2; GM-Tg-cang-IP2851-Ab-1/ GM-Tg-cang-IP2851-Ab-2;
GM-Tg-bovg-IP2851-Ab-1/ GM-Tg-bovg-IP2851-Ab-2; GM-Tg-equg-IP2851-Ab-1/ GM-Tg-equg-IP2851-Ab-2
Products NameAnti-ZSWIM1 monoclonal antibody
Formatmab
Target NameZSWIM1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ZSWIM1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2851-Ag-1Recombinant multi-species ZSWM1/ ZSWIM1/ C20orf162 protein
    ORF Viral VectorpGMLPm004984mouse Zswim1 Lentivirus plasmid
    ORF Viral VectorvGMLPm004984mouse Zswim1 Lentivirus particle


    Target information

    Target IDGM-IP2851
    Target NameZSWIM1
    Gene ID90204,71971,311631,717180,485902,101086298,512243,100071109
    Gene Symbol and Synonyms2410003H12Rik,C20orf162,ZSWIM1
    Uniprot AccessionQ9BR11
    Uniprot Entry NameZSWM1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168612
    Target ClassificationN/A

    The target: ZSWIM1, gene name: ZSWIM1, also named as C20orf162. Predicted to enable zinc ion binding activity. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.